In just one month, we will be heading to RNA Leaders Europe 2026 taking place on 18–19 March in Vienna. We’re excited to join leading experts and innovators shaping the rapidly evolving world of RNA therapeutics.
SyVento BioTech will be represented by: Eliza Milewicz, SVP, Chief Commercial Officerand Dominik Lipka, Chief Technology Officer.
This event is a great opportunity to learn more about the comprehensive CDMO services SyVento BioTech provides, supporting the development and manufacturing of advanced therapeutics, with a strong focus on mRNA/LNP technologies.
Our state-of-the-art manufacturing facility features:
▸A modern production line based on Single Use Systems (SUS)
▸A fully integrated Fill & Finish line
▸Flexible capabilities from early development to GMP commercial production
We are committed to helping partners accelerate their programs with scientific excellence, operational efficiency, and a collaborative approach at every stage.
If you’re attending RNA Leaders Europe, we would be delighted to connect.
👉 Book a meeting with our team and explore how we can support your next breakthrough.
See you in Vienna!
